EC
IRLA

EcoR1 Capital’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

EcoR1 Capital’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-250
Closed -$1.25M – 51
2019
Q3 		$1.25M Buy
+250
New +$1.54M 0.16% 34

Other funds holding IRLA

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $31.9B AUM 28.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

EcoR1 Capital's IRLA Position: Q4 2019 in Review

EcoR1 Capital sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q4 2019, closing a stake of 250 shares — an estimated $1.25M sold.

EcoR1 Capital first reported a position in IRLA in Q3 2019 and held it in 1 quarter. The position peaked at $1.25M in Q3 2019. 50 funds tracked by Wall St. Rank hold IRLA as of Q4 2019.

  • EcoR1 Capital reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • EcoR1 Capital sold 250 IRulya Therapeutics Inc. Common Stock shares in Q4 2019, an estimated $1.25M.
  • EcoR1 Capital first reported a position in IRulya Therapeutics Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • EcoR1 Capital's IRulya Therapeutics Inc. Common Stock position peaked at $1.25M in Q3 2019.
  • 50 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q4 2019.

Based on EcoR1 Capital's 13F filing for Q4 2019, filed 14 Feb 2020.